Breast cancer is the most common cancer in women worldwide and it is still one of the leading causes of morbi-mortality, therefore being a major concern. 2-FDG PET/CT is commonly used in the clinical management of patients with breast cancer, with significant impact on clinical management. Currently, there is robust evidence supporting the usefulness of […]
The webinar will cover the most relevant methodological aspects of nuclear medicine techniques in paediatric nephrourology, with particular attention to the choice of the radiotracer, the correct patient preparation, and the acquisition protocol. Some typical cases will show the main points of image processing and results visualization. The clinical part will deal with hydronephrosis and […]
This course provides a comprehensive overview of nuclear medicine imaging of coronary artery disease. General aspects, details of radiotracers utilised, examination protocols and case examples of myocardial perfusion imaging (MPI) using PET and SPECT will be discussed at the event. The focus here will be on the quantification of data (e.g. abnormality scores, myocardial blood […]
The rapid development in machine learning has generated new artificial intelligence (AI) based methods for improving dosimetry within nuclear medicine. This webinar will present the current status of AI within the dosimetry workflow for targeted radionuclide therapy. First, AI methods for reducing SPECT acquisition times, noise reduction and scatter correction will be covered. Thereafter, AI […]
The course has a hybrid format with on-site lectures and hands-on practical and technic sessions, It will cover the basic and some advanced and future aspects of Radioguided surgery with a focus on the technologist's work and support the multidisciplinary team in charge of Radioguided procedures. Target Audience Learning Objectives Faculty Registration Details Event Overview
While PET imaging with radionuclides such as F18 and Ga68 have proven to provide high quality diagnostic imaging, imaging with other radionuclides can be more challenging. Zr-89 is one such radionuclide. Although Zr-89 has advantageous labelling properties for cell imaging and the imaging of monoclonal antibodies, the radionuclide is non-ideal imaging qualities mostly due to […]
The advent of FDA approved anti-AB drugs such as Aducanumab and Lecanemab is changing not only the therapeutic prospectives for patients but also the diagnostic flow-charts. However, due to differences in clinical processes and insurance systems in each country, the use of amyloid PET in the diagnostic tree currently varies from country to country. In Europe, […]
With the arrival of new therapeutic tracers, nuclear medicine has a new arsenal to treat metastatic bone pain. This presentation aims to give the keys to define the place of nuclear medicine among other treatment modalities (external beam therapy, medical treatment, chemotherapy). Learning Objectives: Refresh knowledge on the pathophysiology of pain and present the opportunities […]
The course will offer a comprehensive overview of basic, theoretical and practical evidence-based concepts needed for a deep and thoughtful understanding of the use of FDG (FDG) Brain PET, amyloid (Amy) PET and DaT SPECT in Neurological Disorders. A brief introduction will be given on the position that each imaging technique holds in the recent […]
This online course is part of a long line of research methodology which is aimed at providing interested participants with information about the preclinical development and clinical translation, as well as the design, conductance and reporting of clinical research trials, with a specific emphasis on radiopharmaceuticals for both diagnostic and therapeutic applications. These first two […]
more information coming soon Faculty Event Overview
European School of Multimodality Imaging & Therapy (ESMIT)
Schmalzhofgasse 26
1060 Vienna
Austria
phone +43 1 890 44 27
e-mail esmit@eanm.org
